Capsovision Inc (CV)

$5.52 +0.16 (2.99%)
Market Cap 258.57M
Revenue (ttm) 341.92M
Net Income (ttm) 20.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 6.13%
Debt to Equity Ratio 0.00
Volume 181,500
Avg Vol 338,880
Day's Range N/A - N/A
Shares Out 46.84M
Stochastic %K 100%
Beta N/A
Analysts Sell
Price Target $10.50

Company Profile

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. It offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). The company also provides CapsoClou...

Industry: Medical Devices
Sector: Healthcare
Phone: 408 624 1488
Fax: 408 370 4795
Address:
18805 Cox Avenue, Suite 250, Saratoga, United States
focafoca99
focafoca99 Mar. 14 at 10:43 PM
$CV amended its original development agreement, so whatever they are building is still evolving in the real world.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 28 at 1:38 AM
$CV RSI: 58.36, MACD: -0.3633 Vol: 0.26, MA20: 4.98, MA50: 7.17 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
flowerchefstocks
flowerchefstocks Feb. 24 at 5:06 PM
$CV The pharmacy Benefit business has been a real problem and all the regulations coming down is a drag on revenues but I think no one is talking about the cost structure. There is a high percentage of cost in the verification process of a prescription. This all goes away if they move to a smart contract and start licensing this technology from $DVLT. This article just makes so much sense. If you cant beat up the drug companies anymore lower your cost structure to nothing using blockchain technology. It eliminates a ton of redundancies. https://www.zerohedge.com/news/2026-02-24/600-billion-prescription-drug-cartel-just-got-disrupted-and-two-small-cap-stocks
0 · Reply
6GodEnergy
6GodEnergy Feb. 24 at 12:23 AM
”@SqueezeSharkie on a different level |better than 90% of the traders on this platform. If you’re not tuned in, that’s a miss, make sure to follow him doesn’t cost you anything but a simple click💎 $CV $JCSE $AEHL $ZONE multiday runners?
1 · Reply
6GodEnergy
6GodEnergy Feb. 23 at 5:34 PM
/@SqueezeSharkie operating on another level 🧠❄️ ,Cold vision, real substance. It doesn’t cost you anything but a click, make sure to follow him!! $CV $VGZ $TURB $BYND ^^
0 · Reply
6GodEnergy
6GodEnergy Feb. 23 at 5:34 PM
[@SqueezeSharkie operating on another level 🧠❄️ Cold vision, real substance. It doesn’t cost you anything but a click, make sure to follow him🔥 $EDTK $RCT $CV $WKSP }
0 · Reply
FeliciaMath
FeliciaMath Jan. 26 at 7:29 PM
sold $CV today. break even.
0 · Reply
FeliciaMath
FeliciaMath Jan. 24 at 6:32 PM
losing patience with $CV. may sell next week
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 24 at 6:49 AM
$CV Current Stock Price: $6.00
0 · Reply
FeliciaMath
FeliciaMath Jan. 14 at 7:19 PM
bought $CV at 6.01
0 · Reply
Latest News on CV
CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026

Mar 12, 2026, 4:05 PM EDT - 3 days ago

CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026

CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference

Nov 20, 2025, 4:05 PM EST - 4 months ago

CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference

CapsoVision to Release Third Quarter 2025 Financial Results on Thursday, November 13, 2025

Oct 30, 2025, 4:05 PM EDT - 4 months ago

CapsoVision to Release Third Quarter 2025 Financial Results on Thursday, November 13, 2025

CapsoVision to Release Second Quarter 2025 Financial Results on Thursday, August 14, 2025

Jul 31, 2025, 4:05 PM EDT - 8 months ago

CapsoVision to Release Second Quarter 2025 Financial Results on Thursday, August 14, 2025

CapsoVision Announces Closing of Initial Public Offering

Jul 3, 2025, 11:50 AM EDT - 9 months ago

CapsoVision Announces Closing of Initial Public Offering

CapsoVision Announces Pricing of Initial Public Offering

Jul 1, 2025, 9:08 PM EDT - 9 months ago

CapsoVision Announces Pricing of Initial Public Offering

U.S. IPO Weekly Recap: Consumer Collections Firm Leads 4 IPO Week, As Two Billion Dollar Listings Join The Pipeline

Jun 28, 2025, 4:20 AM EDT - 9 months ago

U.S. IPO Weekly Recap: Consumer Collections Firm Leads 4 IPO Week, As Two Billion Dollar Listings Join The Pipeline

BPAC CAEP COSO FMFC HCHL JCAP JLHL

CapsoVision Proposes IPO Terms For GI Tract Imaging Capsule Technology

Jun 2, 2025, 10:31 AM EDT - 10 months ago

CapsoVision Proposes IPO Terms For GI Tract Imaging Capsule Technology

Medical device maker CapsoVision files for a $30 million IPO

May 9, 2025, 5:52 PM EDT - 11 months ago

Medical device maker CapsoVision files for a $30 million IPO

CapsoVision IPO Registration Document (S-1)

May 9, 2025, 4:11 PM EDT - 11 months ago

CapsoVision IPO Registration Document (S-1)

focafoca99
focafoca99 Mar. 14 at 10:43 PM
$CV amended its original development agreement, so whatever they are building is still evolving in the real world.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 28 at 1:38 AM
$CV RSI: 58.36, MACD: -0.3633 Vol: 0.26, MA20: 4.98, MA50: 7.17 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
flowerchefstocks
flowerchefstocks Feb. 24 at 5:06 PM
$CV The pharmacy Benefit business has been a real problem and all the regulations coming down is a drag on revenues but I think no one is talking about the cost structure. There is a high percentage of cost in the verification process of a prescription. This all goes away if they move to a smart contract and start licensing this technology from $DVLT. This article just makes so much sense. If you cant beat up the drug companies anymore lower your cost structure to nothing using blockchain technology. It eliminates a ton of redundancies. https://www.zerohedge.com/news/2026-02-24/600-billion-prescription-drug-cartel-just-got-disrupted-and-two-small-cap-stocks
0 · Reply
6GodEnergy
6GodEnergy Feb. 24 at 12:23 AM
”@SqueezeSharkie on a different level |better than 90% of the traders on this platform. If you’re not tuned in, that’s a miss, make sure to follow him doesn’t cost you anything but a simple click💎 $CV $JCSE $AEHL $ZONE multiday runners?
1 · Reply
6GodEnergy
6GodEnergy Feb. 23 at 5:34 PM
/@SqueezeSharkie operating on another level 🧠❄️ ,Cold vision, real substance. It doesn’t cost you anything but a click, make sure to follow him!! $CV $VGZ $TURB $BYND ^^
0 · Reply
6GodEnergy
6GodEnergy Feb. 23 at 5:34 PM
[@SqueezeSharkie operating on another level 🧠❄️ Cold vision, real substance. It doesn’t cost you anything but a click, make sure to follow him🔥 $EDTK $RCT $CV $WKSP }
0 · Reply
FeliciaMath
FeliciaMath Jan. 26 at 7:29 PM
sold $CV today. break even.
0 · Reply
FeliciaMath
FeliciaMath Jan. 24 at 6:32 PM
losing patience with $CV. may sell next week
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 24 at 6:49 AM
$CV Current Stock Price: $6.00
0 · Reply
FeliciaMath
FeliciaMath Jan. 14 at 7:19 PM
bought $CV at 6.01
0 · Reply
REDBEAR
REDBEAR Jan. 13 at 6:41 PM
$CV stocktwits, wtf is this? fix it. i need to read the comments and ask if this is a good buy?
3 · Reply
garygb
garygb Jan. 11 at 3:03 PM
$CV This is having a bad year. Down and forgotten while sitting on the leading edge of ai in medicine. Best longshot I know of. Doubling down and holding tight.
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 5:37 PM
$CV is bringing AI into capsule endoscopy — and FDA is the next gate. CapsoVision has submitted an FDA 510(k) to add an AI-assisted reading module to CapsoCam Plus, aiming to boost diagnostic accuracy and streamline clinical reviews. 🧠⚕️ See why this AI upgrade could be a meaningful catalyst 👉 https://www.zacks.com/stock/news/2811389/capsovision-submits-fda-510k-for-ai-assisted-module-in-capsocam-plus?cid=sm-stocktwits-2-2811389-teaser-27207&ADID=SYND_STOCKTWITS_TWEET_2_2811389_TEASER_27207
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 4:17 PM
$CV drops 7.7% post-announcement — what’s behind the slide? 🤔 Despite a 205.4% surge over six months, the recent dip coincides with CV's FDA submission for an AI reading feature in its CapsoCam Plus system. This AI-enhancement aims to boost diagnostic accuracy and efficiency but needs clearance first. Full scoop here 👉 https://www.zacks.com/stock/news/2811389/capsovision-submits-fda-510k-for-ai-assisted-module-in-capsocam-plus?cid=sm-stocktwits-2-2811389-body-27182&ADID=SYND_STOCKTWITS_TWEET_2_2811389_BODY_27182
0 · Reply
medguy
medguy Jan. 1 at 12:12 AM
Looking for a bounce $AFJK $TRON $CV $CORT
0 · Reply
Easteregg
Easteregg Dec. 30 at 5:46 PM
$CV Does their technology have any advantage over the competition? Anyone knowledgeable about this company?
0 · Reply
topstockalerts
topstockalerts Dec. 29 at 1:58 PM
Pre Market Top Gainers PT2 $ANL $AFJK $SOPA $CV $BRLS
0 · Reply
topstockalerts
topstockalerts Dec. 22 at 3:01 PM
Top Gainers PT2 $ADEA $EQ.X $LSH $BYSI $CV
0 · Reply
topstockalerts
topstockalerts Dec. 22 at 1:01 PM
Pre Market Top Gainers PT2 $CV $FTCI $NUWE $AAME $VELO
0 · Reply
Brandz141
Brandz141 Dec. 19 at 9:01 PM
$LUNR hold my beer said $CV 😂
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 17 at 3:54 PM
$CV
0 · Reply
BioGem
BioGem Dec. 16 at 5:08 AM
$CV Will build a short position in this huge bubble. Not sure if anyone has looked at their strange financials: -Revenue near 3M per Q has basically no growth. -Losses are deeper by the day with bigger cash burn. -Cash is near zero by early 2026. -Lock up period is in a few weeks. -A big offering and dilution is a certainty. -No catalyst for the next 6 months. -Even the pumper analysts have a price target of $5-6.
0 · Reply